OIS | VIRTUAL

OIS VIRTUAL SHOWCASES COMING SOON

Be among the companies featured in our Virtual OIS, a series of webcasts focused on therapies in development to address Glaucoma, Dry Eye, Presbyopia, Myopia, Keratoconus, Drug Delivery, and Retinal Degenerative Diseases.

OIS ANTERIOR SEGMENT 2020

EVENT POSTPONED - STAY TUNED FOR NEW DATE

This Ophthalmology Innovation Summit unites over 600 Corporate, Clinical and Capital leaders to collaborate on the development and commercialization of innovative therapies for the anterior segment.

OIS ISRAEL 2020

JUNE 15, 2020 | TEL AVIV, ISRAEL

Ophthalmology Innovation Summit is proud to announce our first international meeting in the beautiful city of Tel Aviv, Israel.

 

OIS RETINA 2020

JULY 23, 2020 | SEATTLE, WA

This Ophthalmology Innovation Summit unites 300 Corporate, Clinical and Capital leaders to collaborate on the development and commercialization of innovative therapies for the posterior segment.

12TH ANNUAL OIS 2020

NOVEMBER 12, 2020 | LAS VEGAS, NV

The Ophthalmology Innovation Summit began in 2009 and now unites over 1,200 Corporate, Clinical and Capital leaders to collaborate on the development and commercialization of innovative drugs, devices and diagnostics to address unmet vision disorders.

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

LATEST NEWS

Keeping an "Eye on Innovation" Through News & Analysis

AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

May 20 2020

AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

Now that it has closed on its $63 billion acquisition of Allergan, AbbVie has significantly expanded its revenue base, which could help cushion the blow ...
Eyenuk’s EyeArt AI System Showing Its Value

May 13 2020

Eyenuk’s EyeArt AI System Showing Its Value

Eyenuk Inc.’s first product, the EyeArt AI eye screening system, is an artificial intelligence (AI) technology for autonomous detection of diabetic retinopathy that’s been tested ...
New J&J Vision CMO Steps onto a Very Large Stage

May 7 2020

New J&J Vision CMO Steps onto a Very Large Stage

The stage of ophthalmic innovation has hosted a multitude of new acts, people going from established companies to start-ups and vice versa and back again, ...
With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery

April 29 2020

With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery

Developing a delivery system to replace eye drops has been an important unmet need in ophthalmology. Drops are difficult or impossible for some patients to ...
Covid-19 Impact on Healthcare Company Valuations & Financings

April 22 2020

Covid-19 Impact on Healthcare Company Valuations & Financings

The turmoil in the stock market over the past month or so has sent leading healthcare indices reeling, casting a cloud over the financing that ...
Aldeyra Eyes Lucrative DED, Conjunctivitis Markets

April 16 2020

Aldeyra Eyes Lucrative DED, Conjunctivitis Markets

Dry eye disease and allergic conjunctivitis are two flourishing markets within ophthalmology. The dry eye market is expected to climb to $5.1 billion by the ...

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.